Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
ABX 51.81 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.82 +9.7% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2% ABX 51.81 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.82 +9.7% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.45 +0.3% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.315 −1.6% DEX 0.395 +2.6% WMS 0.040 +0.0% EMPR 0.830 +1.2%
Other Routine +

The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification

Compliance milestones unlock e-commerce scaling, but regulatory clarity remains the true catalyst.

By The Northwire Desk — AI Analysis Jun 23, 2026 · 07:31 BPC · 0.465 The Precision Peptide Company Inc.
Executive Summary
  • The Precision Peptide Company has secured the LegitScript Healthcare Merchant Certification, an independent third-party validation of its compliance, transparency, and consumer-safety standards.
  • The certification is a recognized prerequisite for processing payments and running advertisements on major platforms including Visa, Mastercard, Google, Microsoft, and Meta.
  • This milestone directly removes platform-specific compliance barriers, unlocking broader access to critical payment processors and advertising networks to drive e-commerce revenue.
  • The announcement follows a rapid sequence of infrastructure builds: a U.S.-based telehealth/prescription partnership (June 9), a 503A sterile compounding agreement ensuring 100% U.S. manufacturing (June 2), and a commercial order for 20,000 BPC-157 transdermal patches (May 26).
Material Impact
  • The certification is a necessary operational step for any direct-to-consumer (DTC) wellness brand scaling digital sales and paid advertising. It does not represent new revenue, a transformative contract, or a change in the company's fundamental business model.
  • By enabling payment processing and ad placement on major platforms, the company removes friction from its e-commerce funnel. However, the actual conversion of this capability into top-line growth depends on the successful commercial launch of its patch and the execution of its marketing partnerships.
  • The news is incremental to the company's stated roadmap of building compliant, U.S.-based infrastructure ahead of regulatory developments. It confirms operational progress but does not alter the risk/reward profile materially.
BPC · Price
Company Overview
  • The Precision Peptide Company is a publicly traded wellness company focused on advanced peptide formulations, primarily BPC-157 and Thymosin Alpha-1.
  • The company operates a direct-to-consumer model, selling products via its website and expanding into prescription-based telehealth channels.
  • Key strategic pillars include 100% U.S.-based compounding through a 503A pharmacy, a telehealth partnership covering all 50 U.S. states, and an exclusive marketing agreement with MMA Inc. to access a global combat sports ecosystem.
  • The company emphasizes third-party testing, U.S. manufacturing compliance, and regulatory alignment as core differentiators in an evolving peptide market.
Read the original news release →

More from The Precision Peptide Company Inc.

Jun 11, 2026 · 17:01

Pre-revenue peptide developer secures at-market capital to fund U.S. commercial rollout amid regulatory tailwinds.

Financings Jun 09, 2026 · 07:31

Building compliant U.S. telehealth and compounding infrastructure ahead of pivotal July FDA PCAC review.

M&A / Property Jun 02, 2026 · 07:01

The Precision Peptide Company Inc.

Financings May 26, 2026 · 07:31

Precision Peptide Advances Commercial Launch with MMA Partnership Backing

Other May 21, 2026 · 09:00

McGregor and Trump Jr. muscle into peptide marketing pact, but needle-free patch launch remains the real prize

Financings May 21, 2026 · 07:31

Precision Peptide Solidifies MMA Partnership While Regulatory Clock Ticks Toward July Review

M&A / Property